Unfurling of the band 4.1, ezrin, radixin, moesin (FERM) domain of the merlin tumor suppressor

Protein Science

Volumn 20, Issue 12, 2011, Pages 2113-2120

  Yogesha, S D ^a   Sharff, Andrew J ^b   Giovannini, Marco ^c   Bricogne, Gerard ^b   Izard, Tina ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b GLOBAL PHASING LTD   (United Kingdom)

^c HOUSE EAR INSTITUTE   (United States)

Author keywords

Actin cytoskeleton; Adherens junctions; Crystallography; Neurofibromatosis

Indexed keywords

ERYTHROCYTE BAND 4.1 PROTEIN; EZRIN; MERLIN; MOESIN; RADIXIN;

ARTICLE; CRYSTAL STRUCTURE; CRYSTALLIZATION; DIMERIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN STRUCTURE;

AMINO ACID MOTIFS; CRYSTALLOGRAPHY, X-RAY; HUMANS; MODELS, MOLECULAR; NEUROFIBROMIN 2; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY;

MUS;

EID: 81755172093     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1002/pro.751     Document Type: Article

References (50)

1. McClatchey AI, Giovannini M (2005) Membrane organization and tumorigenesis - the NF2 tumor suppressor, Merlin. Genes Dev 19:2265-2277. (Pubitemid 41396902)
2. Stemmer-Rachamimov AO, Xu L, Gonzalez-Agosti C, Burwick JA, Pinney D, Beauchamp R, Jacoby LB, Gusella JF, Ramesh V, Louis DN (1997) Universal absence of merlin, but not other ERM family members, in schwannomas. Am J Pathol 151:1649-1654. (Pubitemid 27527927)
3. Ruttledge MH, Sarrazin J, Rangaratnam S, Phelan CM, Twist E, Merel P, Delattre O, Thomas G, Nordenskjold M, Collins VP, Dumanski JP, Rouleau GA (1994) Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet 6:180-184. (Pubitemid 24188600)
4. Bianchi AB, Mitsunaga SI, Cheng JQ, Klein WM, Jhanwar SC, Seizinger B, Kley N, Klein-Szanto AJ, Testa JR (1995) High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas. Proc Natl Acad Sci USA 92:10854-10858.
5. Giovannini M, Robanus-Maandag E, van der Valk M, Niwa-Kawakita M, Abramowski V, Goutebroze L, Woodruff JM, Berns A, Thomas G (2000) Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes Dev 14:1617-1630. (Pubitemid 30460911)
6. McClatchey AI, Saotome I, Mercer K, Crowley D, Gusella JF, Bronson RT, Jacks T (1998) Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. Genes Dev 12:1121-1133. (Pubitemid 28194048)
7. Lallemand D, Curto M, Saotome I, Giovannini M, McClatchey AI (2003) NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions. Genes Dev 17:1090-1100. (Pubitemid 36534984)
8. Curto M, Cole BK, Lallemand D, Liu CH, McClatchey AI (2007) Contact-dependent inhibition of EGFR signaling by Nf2/Merlin. J Cell Biol 177:893-903. (Pubitemid 46873094)
9. Maitra S, Kulikauskas RM, Gavilan H, Fehon RG (2006) The tumor suppressors Merlin and expanded function cooperatively to modulate receptor endocytosis and signaling. Curr Biol 16:702-709.
10. Brault E, Gautreau A, Lamarine M, Callebaut I, Thomas G, Goutebroze L (2001) Normal membrane localization and actin association of the NF2 tumor suppressor protein are dependent on folding of its N-terminal domain. J Cell Sci 114:1901-1912. (Pubitemid 32530045)
11. James MF, Manchanda N, Gonzalez-Agosti C, Hartwig JH, Ramesh V (2001) The neurofibromatosis 2 protein product merlin selectively binds F-actin but not G-actin, and stabilizes the filaments through a lateral association. Biochem J 356:377-386. (Pubitemid 32532348)
12. Xu HM, Gutmann DH (1998) Merlin differentially associates with the microtubule and actin cytoskeleton. J Neurosci Res 51:403-415.
13. Bretscher A, Edwards K, Fehon RG (2002) ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol 3:586-599.
14. Curto M, McClatchey AI (2008) Nf2/Merlin: a coordinator of receptor signalling and intercellular contact. Br J Cancer 98:256-262. (Pubitemid 351161230)
15. Pearson MA, Reczek D, Bretscher A, Karplus PA (2000) Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain. Cell 101:259-270.
16. Smith WJ, Nassar N, Bretscher A, Cerione RA, Karplus PA (2003) Structure of the active N-terminal domain of Ezrin. Conformational and mobility changes identify keystone interactions. J Biol Chem 278:4949-4956. (Pubitemid 36801003)
17. Kang BS, Cooper DR, Devedjiev Y, Derewenda U, Derewenda ZS (2002) The structure of the FERM domain of merlin, the neurofibromatosis type 2 gene product. Acta Crystallogr D Biol Crystallogr 58:381-391. (Pubitemid 34248847)
18. Shimizu T, Seto A, Maita N, Hamada K, Tsukita S, Hakoshima T (2002) Structural basis for neurofibromatosis type 2. Crystal structure of the merlin FERM domain. J Biol Chem 277:10332-10336. (Pubitemid 34968150)
19. Edwards SD, Keep NH (2001) The 2.7 A crystal structure of the activated FERM domain of moesin: an analysis of structural changes on activation. Biochemistry 40:7061-7068. (Pubitemid 32554027)
20. Matsui T, Maeda M, Doi Y, Yonemura S, Amano M, Kaibuchi K, Tsukita S (1998) Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association. J Cell Biol 140:647-657. (Pubitemid 28134067)
21. Shaw RJ, Paez JG, Curto M, Yaktine A, Pruitt WM, Saotome I, O'Bryan JP, Gupta V, Ratner N, Der CJ, Jacks T, McClatchey AI (2001) The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling. Dev Cell 1:63-72. (Pubitemid 33586069)
22. Hamada K, Shimizu T, Yonemura S, Tsukita S, Hakoshima T (2003) Structural basis of adhesion-molecule recognition by ERM proteins revealed by the crystal structure of the radixin-ICAM-2 complex. EMBO J 22:502-514. (Pubitemid 36193595)
23. Terawaki S, Maesaki R, Okada K, Hakoshima T (2003) Crystallographic characterization of the radixin FERM domain bound to the C-terminal region of the human Na+/H+-exchanger regulatory factor (NHERF). Acta Crystallogr D Biol Crystallogr 59:177-179. (Pubitemid 36117230)
24. Matsui T, Yonemura S, Tsukita S (1999) Activation of ERM proteins in vivo by Rho involves phosphatidylinositol 4-phosphate 5-kinase and not ROCK kinases. Curr Biol 9:1259-1262. (Pubitemid 29527153)
25. Fievet BT, Gautreau A, Roy C, Del Maestro L, Mangeat P, Louvard D, Arpin M (2004) Phosphoinositide binding and phosphorylation act sequentially in the activation mechanism of ezrin. J Cell Biol 164:653-659. (Pubitemid 38282949)
26. Laulajainen M, Muranen T, Carpen O, Gronholm M (2008) Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton. Oncogene 27:3233-3243. (Pubitemid 351733388)
27. Rong R, Surace EI, Haipek CA, Gutmann DH, Ye K (2004) Serine 518 phosphorylation modulates merlin intramolecular association and binding to critical effectors important for NF2 growth suppression. Oncogene 23:8447-8454. (Pubitemid 39540795)
28. Alfthan K, Heiska L, Gronholm M, Renkema GH, Carpen O (2004) Cyclic AMP-dependent protein kinase phosphorylates merlin at serine 518 independently of p21-activated kinase and promotes merlin-ezrin heterodimerization. J Biol Chem 279:18559-18566. (Pubitemid 38623276)
29. Nguyen R, Reczek D, Bretscher A (2001) Hierarchy of merlin and ezrin N- and C-terminal domain interactions in homo- and heterotypic associations and their relationship to binding of scaffolding proteins EBP50 and E3KARP. J Biol Chem 276:7621-7629.
30. Murthy A, Gonzalez-Agosti C, Cordero E, Pinney D, Candia C, Solomon F, Gusella J, Ramesh V (1998) NHE-RF, a regulatory cofactor for Na(+)-H+ exchange, is a common interactor for merlin and ERM (MERM) proteins. J Biol Chem 273:1273-1276. (Pubitemid 28133639)
31. Morrison H, Sherman LS, Legg J, Banine F, Isacke C, Haipek CA, Gutmann DH, Ponta H, Herrlich P (2001) The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev 15:968-980. (Pubitemid 32323547)
32. Hamada K, Shimizu T, Matsui T, Tsukita S, Hakoshima T (2000) Structural basis of the membrane-targeting and unmasking mechanisms of the radixin FERM domain. EMBO J 19:4449-4462.
33. Li Q, Nance MR, Kulikauskas R, Nyberg K, Fehon R, Karplus PA, Bretscher A, Tesmer JJ (2007) Self-masking in an intact ERM-merlin protein: an active role for the central alpha-helical domain. J Mol Biol 365:1446-1459. (Pubitemid 46055267)
34. Scoles DR, Huynh DP, Morcos PA, Coulsell ER, Robinson NG, Tamanoi F, Pulst SM (1998) Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin. Nat Genet 18:354-359. (Pubitemid 28158164)
35. Gutmann DH, Geist RT, Xu H, Kim JS, Saporito-Irwin S (1998) Defects in neurofibromatosis 2 protein function can arise at multiple levels. Hum Mol Genet 7:335-345. (Pubitemid 28120620)
36. Stokowski RP, Cox DR (2000) Functional analysis of the neurofibromatosis type 2 protein by means of disease-causing point mutations. Am J Hum Genet 66:873-891. (Pubitemid 30470490)
37. Lawrence MC, Colman PM (1993) Shape complementarity at protein/protein interfaces. J Mol Biol 234:946-950. (Pubitemid 24027225)
38. Lallemand D, Saint-Amaux AL, Giovannini M (2009) Tumor-suppression functions of merlin are independent of its role as an organizer of the actin cytoskeleton in Schwann cells. J Cell Sci 122:4141-4149.
39. LaJeunesse DR, McCartney BM, Fehon RG (1998) Structural analysis of Drosophila merlin reveals functional domains important for growth control and subcellular localization. J Cell Biol 141:1589-1599. (Pubitemid 28309173)
40. Kitano K, Yusa F, Hakoshima T (2006) Structure of dimerized radixin FERM domain suggests a novel masking motif in C-terminal residues 295-304. Acta Crystallogr Sect F Struct Biol Cryst Commun 62:340-345.
41. Henrick K, Thornton JM (1998) PQS: a protein quaternary structure file server. Trends Biochem Sci 23:358-361. (Pubitemid 28461869)
42. Janin J, Rodier F (1995) Protein-protein interaction at crystal contacts. Proteins 23:580-587. (Pubitemid 26009521)
43. Vonrhein C, Flensburg C, Keller P, Sharff A, Smart O, Paciorek W, Womack T, Bricogne G (2011) Data processing and analysis with teh autoPROC toolbox. Acta Crystallogr D Biol Crystallogr 67:293-302.
44. Kabsch W (2010) XDS. Acta Crystallogr D Biol Crystallogr 66:125-132.
45. Evans P (2006) Scaling and assessment of data quality. Acta Crystallogr D Biol Crystallogr 62:72-82.
46. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ (2007) Phaser crystallographic software. J Appl Crystallogr 40:658-674. (Pubitemid 47080256)
47. Collaborative Computational Project N (1994) The CCP4 Suite: programs for protein crytsallography. Acta Crystallogr D Biol Crystallogr D50:760-763.
48. Bricogne G, Blanc E, Brandl M, Flensburg C, Keller P, Paciorek P, Roversi P, Sharff A, Smart O, Vonrhein C, Womack T (2010) BUSTER version 2.9. Cambridge, United Kingdom: Global Phasing Ltd.
49. Emsley P, Cowtan K (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60:2126-2132. (Pubitemid 41742764)
50. Smart OS, Brandl M, Flensburg C, Keller P, Paciorek W, Vonrhein C, Womack TO, Bricogne G (2008) Refinement with local structure similarity restraints (LSSR) enables exploitation of information from related structures and facilitates use of NCS. Abstr Annu Meet Am Crystallogr Assoc, Knoxville, TN. abstr. TP139.